The Turnaround: New ALS Drug
Photo: Christine Olsson/TT

The Turnaround: New ALS Drug Tofersen Recommended

The NT Council is now recommending the ALS drug Tofersen for patients with a specific type of ALS, P4 Norrbotten reports. The drug, known as Qalsody in Sweden, is already used in several European countries.

Advertisement

Previously, the country's regions had been advised against using the drug, but now the NT Council, an expert group mandated to make recommendations to the regions, has reversed its position on the issue.

The drug may be given to ALS patients after consultation with the NT Council's National Treatment Council for ALS.

Tofersen is currently available in several European countries, including Germany and Belgium. The drug was approved for use in the US in 2023 and in the EU in 2024.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Sweden

All